Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Overview of Protein Metabolism

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Protein Absorption

Protein Absorption

Proteins in the gastrointestinal tract typically come from food, but they can also originate from disintegrated cells or secreted enzymes. In the stomach, the enzyme pepsin breaks down these proteins into polypeptides. The fragments then move into the duodenum as a semi-fluid mass called chyme. Pancreatic proteases, such as trypsin and chymotrypsin, and intestinal brush border enzymes like carboxypeptidases further dismantle the polypeptides into tripeptides, dipeptides, and free amino acids.

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral Nutrition I: Orogastric and Nasogastric Feeding

Enteral nutrition delivers nutrients directly to the stomach or small intestine through a tube. This method is appropriate for patients who cannot eat but still have a functioning digestive system. It is also beneficial for individuals with swallowing difficulties, anorexia, malabsorption, or those who have undergone gastrointestinal (GI) surgery.
Orogastric (OG) and nasogastric (NG) feeding are two standard methods used for enteral nutrition. Enteral nutrition is often preferred over...

Chronic Pancreatitis II: Pathophysiology

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Risk of anti-TNF therapy on pregnancy, breastfeeding, live vaccines and related information in patients with inflammatory bowel disease: Real-world data from a nationwide study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2024

Same author

Infliximab is an effective option in patients with ulcerative colitis previously exposed to full subcutaneous anti-TNF agent: Results from a real-world multicenter study.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2024

Same author

Comparative Risk of Incident Cancer in Patients with Inflammatory Bowel Disease with Prior Non-digestive Malignancy According to Immunomodulator: a Multicentre Cohort Study.

Journal of Crohn's & colitis·2022

Same author

How to Manage Inflammatory Bowel Disease Patients When They Withdraw Anti-Tumour Necrosis Factor [Anti-TNF] Due to Severe Anti-TNF-Induced Skin Lesions? A Multicentre Cohort Study.

Journal of Crohn's & colitis·2022

Same author

Defining and Assessing the Reproducibility of Crohn's Disease Endoscopic Lesions: A Delphi-like Method from the GETAID.

Journal of Crohn's & colitis·2020

Same author

Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study.

Journal of Crohn's & colitis·2020

Search research articles

Related Experiment Video

Updated: Apr 18, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

[Protein-losing enteropathy].

¹Service d'hépato-gastroentérologie, hôpital Henri-Mondor, université Paris Est Créteil, AP-HP, 51, boulevard du Maréchal-de-Lattre-de-Tassigny, 94010 Créteil, France.

La Revue De Medecine Interne

|January 26, 2015

Summary

This summary is machine-generated.

Protein-losing enteropathy involves gastrointestinal protein loss, often due to lymphatic issues or digestive disorders. Diagnosis relies on fecal alpha-1 antitrypsin clearance, with treatment targeting the cause and including dietary changes.

Keywords:

Alpha-1 antitrypsin Alpha-1 antitrypsine Fuite lymphatique Gastro-entéropathie exsudative Hypoalbuminemia Hypoalbuminémie Lymphatic leakage Maladie de Waldmann Protein-losing enteropathy Waldmann's disease Œdème

More Related Videos

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

Related Experiment Videos

Last Updated: Apr 18, 2026

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Ileectomy-induced Bile Overaccumulation in Mouse Intestine

Published on: August 21, 2017

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

A Novel Human Epithelial Enteroid Model of Necrotizing Enterocolitis

Published on: April 10, 2019

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Quantifying Tissue-Specific Proteostatic Decline in Caenorhabditis elegans

Published on: September 7, 2021

Area of Science:

Gastroenterology
Internal Medicine
Clinical Diagnostics

Context:

Protein-losing enteropathy (PLE) is a rare but serious condition characterized by significant protein loss from the gastrointestinal tract.
It presents a diagnostic challenge due to varied underlying etiologies, including lymphatic abnormalities and mucosal disorders.
Clinical suspicion should arise in patients exhibiting chronic diarrhea and peripheral edema.

Purpose:

To elucidate the primary causes of protein-losing enteropathy, differentiating between lymphatic and erosive/non-erosive gastrointestinal origins.
To highlight key diagnostic markers, particularly fecal alpha-1 antitrypsin clearance.
To outline current therapeutic strategies, encompassing etiological treatment and nutritional management.

Summary:

Protein-losing enteropathy (PLE) is defined by excessive gastrointestinal protein loss, stemming from lymphatic leakage or mucosal damage.
Diagnostic evaluation commonly involves assessing fecal alpha-1 antitrypsin clearance.
Etiologies range from lymphatic obstruction and gastrointestinal disorders to cardiac conditions, with primary intestinal lymphangiectasia being less frequent.

Impact:

Improved diagnostic accuracy for protein-losing enteropathy through emphasis on fecal alpha-1 antitrypsin clearance.
Enhanced understanding of PLE pathophysiology, guiding targeted therapeutic interventions.
Clinical guidance for managing patients with chronic diarrhea and edema, improving patient outcomes through tailored dietary and etiological treatments.